Cargando…
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19()
The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation an...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233062/ https://www.ncbi.nlm.nih.gov/pubmed/34182016 http://dx.doi.org/10.1016/j.addr.2021.113848 |